The complex and gradual shift in systemic metabolic and endocrine regulation that occurs during the middle decades of life, typically characterized by changes in body composition, reduced insulin sensitivity, and the onset of hormonal senescence. This transition represents a critical physiological inflection point where the body’s homeostatic resilience begins to diminish, often leading to increased risk for cardiometabolic and cognitive disorders. It is a period of heightened vulnerability to environmental and lifestyle stressors.
Origin
This term arises from the integration of endocrinology, gerontology, and preventative medicine, recognizing that midlife is a distinct physiological stage, not merely a prelude to old age. It specifically highlights the profound impact of declining sex steroids, like estrogen and testosterone, on central and peripheral metabolism. The transition is a measurable phenomenon linking reproductive aging to systemic metabolic health.
Mechanism
Mechanistically, the transition is driven by a reduction in sex hormone and growth hormone signaling, which compromises the efficiency of energy partitioning, leading to increased visceral adiposity and skeletal muscle insulin resistance. This hormonal change contributes to chronic low-grade inflammation and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. The net effect is a systemic metabolic slowdown and a reduced capacity for cellular repair and regeneration.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.